CD19 anticorps
-
- Antigène Voir toutes CD19 Anticorps
- CD19 (CD19 Molecule (CD19))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD19 est non-conjugé
-
Application
- Flow Cytometry (FACS), Immunofluorescence (IF)
- Purification
- Protein G affinity chromatography
- Immunogène
- Human CD19 recombinant protein was used as immunogen for this CD19 antibody.
- Clone
- C19-366
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product CD19 Anticorps primaire
-
anti-CD19 Molecule (CD19) (AA 485-556) antibody
CD19 Reactivité: Humain, Souris, Rat, Mouton FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 151-250) antibodyCD19 Reactivité: Humain, Souris, Rat FACS, WB, ELISA, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 20-291) antibodyCD19 Reactivité: Humain FACS, WB, IHC, ELISA, IF Hôte: Souris Monoclonal 8G11B7 unconjugated
anti-CD19 Molecule (CD19) (C-Term) antibodyCD19 Reactivité: Humain, Souris, Singe, Rat, Mouton, Porc, Boeuf (Vache), Cobaye, Chien, Âne, Chévre, Hamster, Cheval, Lapin, Avian, Cat, Poulet WB Hôte: Chèvre Polyclonal unconjugated
anti-CD19 Molecule (CD19) (pTyr531) antibodyCD19 Reactivité: Humain, Souris FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reactivité: Humain FACS, WB, IF, ICC, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 96-281) antibodyCD19 Reactivité: Humain FACS, IHC, ELISA, Coat, StM Hôte: Souris Monoclonal CD19-3116 unconjugated
anti-CD19 Molecule (CD19) (AA 143-172) antibodyCD19 Reactivité: Humain FACS, WB, IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 160-258) antibodyCD19 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reactivité: Humain FACS, IP Hôte: Souris Monoclonal LT19 unconjugated
-
- Indications d'application
-
Flow Cytometry: 0.5-1 μg/million cells
Immunofluorescence: 0.5-1 μg/mL
Variations in protocols, secondaries and substrates may require the CD19 antibody to be titered up or down for optimal performance. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.2 mg/mL
- Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
- Antigène
- CD19 (CD19 Molecule (CD19))
- Autre désignation
- CD19 (CD19 Produits)
- Synonymes
- anticorps B4, anticorps CVID3, anticorps AW495831, anticorps CD19, anticorps CD19 molecule, anticorps CD19 antigen, anticorps CD19, anticorps Cd19
- Sujet
- CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
- ID gène
- 930
- UniProt
- P15391
- Pathways
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
-
